Fairman Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $777 | Hold |
20
| – | – | ﹤0.01% | 228 |
|
|
2025
Q1 | $3.42K | Sell |
20
-80
| -80% | -$13.7K | ﹤0.01% | 184 |
|
|
2024
Q4 | $3.42K | Hold |
100
| – | – | ﹤0.01% | 201 |
|
|
2024
Q3 | $4.13K | Hold |
100
| – | – | ﹤0.01% | 215 |
|
|
2024
Q2 | $3.89K | Hold |
100
| – | – | ﹤0.01% | 215 |
|
|
2024
Q1 | $4.33K | Hold |
100
| – | – | ﹤0.01% | 203 |
|
|
2023
Q4 | $3.74K | Buy |
+100
| New | +$3.74K | ﹤0.01% | 212 |
|